Jason Alger
CIK 1839111 · View on SEC EDGAR ↗
First SEC filing: Jan. 11, 2021 · Latest: June 3, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 1, 2026 | HCAT | F | 18,804 | $1.37 | $25,761 | 722,840 Direct | -2.54% | Disposed | 24.1% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Initial ownership (Form 3) 6 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 11, 2021 | HCAT | Common Stock | 7,634 | Direct |
| Jan. 11, 2021 | HCAT | Common Stock | 3,125 | Direct |
| Jan. 11, 2021 | HCAT | Stock Options (Right to buy)→ Common Stock (8,070) | 8,070 | Direct |
| Jan. 11, 2021 | HCAT | Stock Options (Right to buy)→ Common Stock (2,242) | 2,242 | Direct |
| Jan. 11, 2021 | HCAT | Stock Options (Right to buy)→ Common Stock (5,200) | 5,200 | Direct |
| Jan. 11, 2021 | HCAT | Stock Options (Right to buy)→ Common Stock (832) | 832 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
HCAT
CFO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $338,333 | — | $826,581 | — | $108,441 | — | $13,800 | $1,287,155 |
| 2023 | $271,250 | — | $495,014 | — | $36,026 | — | $21,325 | $823,615 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.